BenevolentAI
✓ Verified
Healthcare AI
AI drug discovery
Public
BenevolentAI is a clinical-stage AI-enabled drug discovery and development company that uses artificial intelligence and machine learning to discover and develop new medicines for complex diseases. It is publicly listed on Euronext Amsterdam and operates from London with additional presence in New York and Cambridge.
Company Details
- Website
- benevolent.com
- Headquarters
- London, United Kingdom
- Founded
- 2013
- Funding
- Undisclosed
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring